全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Uncontrolled Hypothyroidism with Antiphospholipid Syndrome Resulting in Myxedema Psychosis

DOI: 10.4236/ojpsych.2026.162010, PP. 131-138

Keywords: Case Report, Myxedema Psychosis, Antiphospholipid Syndrome, Hypothyroidism-Induced Psychosis, Autoimmune Hypothyroidism

Full-Text   Cite this paper   Add to My Lib

Abstract:

We describe a female patient with a history of antiphospholipid syndrome, hypothyroidism, and bipolar disorder, who presented with worsening mood and psychotic symptoms following discontinuation of medications. Laboratory evaluations revealed markedly elevated thyroid-stimulating hormone (TSH) of 190 mU/mL. She also had a remote history of intracranial hemorrhage and required long-term anticoagulation with warfarin. We posit that the psychosis and mood presentation were attributable to the interplay between hypothyroidism-induced neuropsychiatric symptoms, decompensation of bipolar disorder, and history of antiphospholipid-related ischemic cerebral injury. Myxedema psychosis was further supported as a diagnosis given her extremely elevated TSH, sudden symptom onset following discontinuation of levothyroxine and other medications, limited improvement with risperidone, and significant clinical improvement after restarting levothyroxine. The etiology of her hypothyroidism was considered to be autoimmune in nature, given its relationship with antiphospholipid syndrome. We emphasize the importance of recognizing autoimmune and endocrine causes of neuropsychiatric symptoms, particularly hypothyroidism, which has a prevalence as high as 18% depending on the population. Optimizing psychiatric medication doses may not be sufficient in these populations, and an accurate prognosis requires accounting for the impact of the untreated hypothyroidism and comorbid autoimmune condition. Our patient was unable to obtain maximum resolution of symptoms until we also treated her hypothyroidism.

References

[1]  Bauer, M., Goetz, T., Glenn, T. and Whybrow, P.C. (2008) The Thyroid-Brain Interaction in Thyroid Disorders and Mood Disorders. Journal of Neuroendocrinology, 20, 1101-1114.
https://doi.org/10.1111/j.1365-2826.2008.01774.x
[2]  Chaker, L., Bianco, A.C., Jonklaas, J. and Peeters, R.P. (2017) Hypothyroidism. The Lancet, 390, 1550-1562.
https://doi.org/10.1016/s0140-6736(17)30703-1
[3]  Heinrich, T.W. and Grahm, G. (2003) Hypothyroidism Presenting as Psychosis: Myxedema Madness Revisited. The Primary Care Companion for CNS Disorders, 5, 260-266.
https://doi.org/10.4088/pcc.v05n0603
[4]  Versini, M. (2017) Thyroid Autoimmunity and Antiphospholipid Syndrome: Not Such a Trivial Association. Frontiers in Endocrinology, 8, Article No. 175.
https://doi.org/10.3389/fendo.2017.00175
[5]  Sardar, S., Habib, M., Sukik, A., Tanous, B., Mohamed, S., Tahtouh, R., et al. (2020) Myxedema Psychosis: Neuropsychiatric Manifestations and Rhabdomyolysis Unmasking Hypothyroidism. Case Reports in Psychiatry, 2020, Article ID: 7801953.
https://doi.org/10.1155/2020/7801953
[6]  Hage, M.P. and Azar, S.T. (2012) The Link between Thyroid Function and Depression. Journal of Thyroid Research, 2012, Article ID: 590648.
https://doi.org/10.1155/2012/590648
[7]  Bernal, J. (2025) Thyroid Hormones in Brain Development and Function.
https://www.ncbi.nlm.nih.gov/books/NBK285549/
[8]  Moeller, K.E., Goswami, R. and Larsen, L.M. (2009) Myxedema Madness Rapidly Reversed with Levothyroxine. The Journal of Clinical Psychiatry, 70, 1607-1608.
https://doi.org/10.4088/jcp.08l04958yel
[9]  Krüger, J., Kraschewski, A. and Jockers-Scherübl, M.C. (2021) Myxedema Madness—Systematic Literature Review of Published Case Reports. General Hospital Psychiatry, 72, 102-116.
https://doi.org/10.1016/j.genhosppsych.2021.08.005
[10]  Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., et al. (2006) International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306.
https://doi.org/10.1111/j.1538-7836.2006.01753.x
[11]  Ruiz-Irastorza, G., Crowther, M., Branch, W. and Khamashta, M.A. (2010) Antiphospholipid Syndrome. The Lancet, 376, 1498-1509.
https://doi.org/10.1016/s0140-6736(10)60709-x
[12]  Lu, D., Song, Z., Gao, Y., Zhang, J. and Guo, X. (2022) Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis. International Journal of Endocrinology, 2022, Article ID: 8271951.
https://doi.org/10.1155/2022/8271951
[13]  Man, Y.L. and Sanna, G. (2022) Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review. Brain Sciences, 12, Article No. 91.
https://doi.org/10.3390/brainsci12010091
[14]  Chaturvedi, S. and McCrae, K.R. (2017) Diagnosis and Management of the Antiphospholipid Syndrome. Blood Reviews, 31, 406-417.
https://doi.org/10.1016/j.blre.2017.07.006
[15]  Gadaen, R. and Tummers-de Lind van Wijngaarden, R. (2021) Hypothyroid Crisis: Oral or Intravenous Treatment? A Report of Two Cases. European Journal of Case Reports in Internal Medicine, 8.
https://doi.org/10.12890/2021_002752
[16]  Wall, C.R. (2000) Myxedema Coma: Diagnosis and Treatment. American Family Physician, 62, 2485-2490.
https://www.aafp.org/pubs/afp/issues/2000/1201/p2485.html

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133